Aegerion Pharmaceuticals Inc. (AEGR)

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger

Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc. and the latter’s subsidiary, Isotope Acquisition Corp., entered into an Agreement......(read more)

September 14 - Hedge Funds, News - Comments

accessibility, achievement, arrow, assertiveness, bar, business, challenge, color, colour, communication, connection, corporate, digitally, finance, front, full, generated,

Why Aegerion Pharmaceuticals, Bank of America and Three Other Stocks are in Spotlight Today?

Markets opened higher on Wednesday as investors await the announcement regarding interest rate hike from the Federal Reserve today. Analysts think that......(read more)

June 15 - Market Movers, News - Comments

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Pharmaceutical And LNG Stocks Are Driving The Market Higher Today

U.S. stocks look set to end today’s trading session in green territory, having gone through a strong selloff last week. Among them there are several......(read more)

December 21 - Market Movers, News - Comments

These Four Stocks Are Leading Today’s Losers Pack for Various Reasons

Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red. Valeant Pharmaceuticals......(read more)

November 10 - Earnings Report, Market Movers, News, Tech - Comments

One Fund is Buying This Biotech Stock Although It’s Losing Smart Money’s Support

Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company. As reported in a recent......(read more)

September 30 - Hedge Funds, News - Comments

Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths

According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler‘s Broadfin Capital has initiated a stake in ContraFect......(read more)

June 22 - Hedge Funds, News - Comments

Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside

To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......(read more)

April 16 - Hedge Funds, News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector

At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with......(read more)

April 2 - Hedge Funds, News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors

Kevin Kotler‘s New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). In a new filing with......(read more)

November 7 - Hedge Funds, News - Comments

Lumber Liquidators Holdings Inc (LL): Steve Cohen’s Point72 Seems To Love This Stock

Steve Cohen’s Point72 Asset Management disclosed today a huge increase in its stake in Lumber Liquidators Holdings Inc (NYSE:LL). The funds affiliated......(read more)

October 16 - Hedge Funds, News - Comments

Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness. Not only did Steve Cohen’s Point72 Asset Management disclose......(read more)

October 15 - Hedge Funds, News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR): Steve Cohen’s Point72 Asset Management Goes Big

Life science is turning out to be an industry sector that most hedgies are convinced will outperform in the near future. In the last few days we have......(read more)

October 15 - Hedge Funds, News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR) & The GEO Group Inc (GEO): Scopia Capital Bets On Biotech Recovery, Gets Out Of Real Estate

Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares......(read more)

August 12 - Hedge Funds, News - Comments

Two Healthcare Stocks That Insiders Are Buying

Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked. In this article, I will......(read more)

May 8 - Insider Trading - Comments

Four Reasons to Buy This Biotechnology Stock

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best......(read more)

September 20 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), Rigel Pharmaceuticals, Inc. (RIGL), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Rise of Little Pharma

Big Pharma gets plenty of hype. But is Little Pharma where investors can make the biggest gains? The answer to that question is a resounding “yes......(read more)

September 17 - News - Comments

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants......(read more)

September 17 - News - Comments

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?

Biotechnology stocks often trade with excessive valuations, until one day, large losses occur. The best way to protect yourself is to be logical when......(read more)

September 16 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline

Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc......(read more)

September 11 - News - Comments

ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)

Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years. The pair announced......(read more)

September 10 - News - Comments

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded......(read more)

September 3 - News - Comments

Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?

Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in......(read more)

August 28 - News - Comments

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are......(read more)

August 26 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO

The Motley Fool’s readers have spoken, and I have heeded their cries. After months of pointing out CEO gaffes and faux pas, I’ve decided......(read more)

August 7 - News - Comments

Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape

As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds......(read more)

August 7 - News - Comments

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Aegerion Pharmaceuticals, Inc. (AEGR): Will This Speculative Cholesterol Treatment Pay Off?

In America, 33.5% of adults over the age of 20 have high LDL (“bad”) cholesterol levels, according to the CDC. Even though the American Heart Association......(read more)

August 7 - News - Comments

ISIS Pharmaceuticals, Inc. (ISIS), Aegerion Pharmaceuticals, Inc. (AEGR): Two Drugs Competing for an One-In-A-Million Disease

Both ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) and Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) have a single drug in the market that help heart patients......(read more)

August 5 - News - Comments

Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases

There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing......(read more)

August 5 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities

The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases......(read more)

August 1 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), Mosaic Co (MOS), Staples, Inc. (SPLS): 3 Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on......(read more)

August 1 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)

Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don’t have to imagine......(read more)

July 5 - News - Comments

ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense

In the last couple of years, the biotechnology industry has been on a roll. The large number of drug approvals and the dreaded patent cliff has positively......(read more)

July 2 - News - Comments

VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out

Biotech companies sometimes get lucky, launching a drug into a new indication where there’s no competition, but more often than not the biotech......(read more)

June 27 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches

There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-......(read more)

June 27 - News - Comments

Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)

Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions......(read more)

June 12 - News - Comments

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals, Inc. (ARNA), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech

With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)

June 10 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), MannKind Corporation (MNKD): 3 Biotech Companies You Should Have Bought This Year

Biotech companies can make you rich if you buy the right ones at the right time. They can also make you poor; but let’s not dwell on the negative......(read more)

June 3 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is currently trading higher by 13% after having its price target raised to $90 by Canaccord – which is......(read more)

May 31 - News - Comments

Why Aegerion Pharmaceuticals, Inc. (AEGR) Shares Jumped

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)

May 29 - News - Comments

Hedge Funds Are Crazy About Aegerion Pharmaceuticals, Inc. (AEGR)

Is Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) a good stock to buy now? Hedge funds are getting more bullish. The number of long hedge fund bets improved......(read more)

May 29 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week

Up, up, and away. That’s the motto for the market as a whole so far this year, but it’s also especially applicable for a select group of stocks......(read more)

May 20 - News - Comments

Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell?

Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) rallied an incredible 31.37% on Thursday after a series of bullish notes that painted a clearer......(read more)

May 20 - News - Comments

What Do Tesla Motors Inc (TSLA) And Netflix, Inc. (NFLX) Have In Common?

The U.S. Producer Price Index signaled deflation in April, industrial production dipped 0.5%, and eurozone GDP clocked in at a worse-than-expected 0.2......(read more)

May 16 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Questcor Pharmaceuticals Inc (QCOR), Aegerion Pharmaceuticals, Inc. (AEGR): Three Booming Biotech Companies

Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these......(read more)

May 4 - News - Comments

Amgen, Inc. (AMGN): What’s Its Next Catalyst?

Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately. Shares are up 23% year to date, but 8% off the high set earlier this month......(read more)

May 1 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Two Orphan Drugmakers With Upcoming Catalysts

Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical......(read more)

April 24 - News - Comments

Sanofi SA (ADR) (SNY), Aegerion Pharmaceuticals, Inc. (AEGR): ISIS Pharmaceuticals, Inc. (ISIS), Big Pharma’s Little Friend

Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) announced Monday a new partnership for developing treatments for Huntington......(read more)

April 8 - News - Comments

Posts Tagged ‘Aegerion Pharmaceuticals Inc. (AEGR)’